Replies to post #43423 on Biotech Values

[DewDiligence]

> NVS – It seems they will need something to offset a possible drop in Lotrel sales if generic Norvasc is launched.<

They expect new sales of Exforge will more than offset any losses on Lotrel. I’m inclined to agree.